FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


MidCap Financial Inks $50MM Debt Agreement with Invuity

March 14, 2017, 07:25 AM
Filed Under: Medical

Invuity, Inc., a medical technology company focused on minimal access surgery, announced that it signed a new debt agreement with MidCap Financial. The new facility consists of a $30 million term loan divided in two tranches. The first tranche of $20 million was funded upon closing and the additional $10 million may be drawn down prior to December 31, 2018 provided that the company achieves certain revenue milestones. The new agreement also consists of a $10 million revolving credit facility (revolver) that may be increased to $20 million at a later date at the company’s request and with approval from MidCap.

“We are pleased to announce this debt financing with MidCap, a leading financing partner in the healthcare space,” commented Philip Sawyer, Invuity’s CEO. “This new and lower cost debt facility strengthens our balance sheet as it allows for potential additional funding of up to $27.5 million to support us as we continue to drive growth through execution of our commercial strategies and introduction of additional innovative, high-value medical devices that leverage our expertise in advanced photonics.”

The MidCap facility carries a 60 month term with interest-only payments on the term loan for the first 24 months. The interest rate on the term loan is 6.5% plus the greater of LIBOR or 1.5%, which at closing resulted in a rate of 8.0%. Borrowings under the revolving line of credit bear interest of 3.25% plus the greater of LIBOR or 1.5% which at closing resulted in a rate of 4.75%. These interest rates are lower than the debt the company replaced. The MidCap agreement requires the company to maintain certain minimum net revenue requirements.

The new agreement replaces the existing $15 million term loan with HealthCare Royalty Partners on which the company was about to start making payments and the $7.5 million revolver with Silicon Valley Bank which the company had yet to utilize.

The company anticipates that with the $20 million in borrowings from the initial tranche of the new term loan facility, after prepayment costs of $17.4 million plus an anticipated $3 million draw on the new revolver facility, the reduced interest costs and deferral of principal payments compared to the original debt will improve its cash position by $7.0 million in 2017.

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.